Actively Recruiting
Oral Hyoscine vs. Topical EMLA vs. Placebo for Pain Reduction During Hysterosalpingography
Led by Cairo University · Updated on 2026-02-03
102
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
Sponsors
C
Cairo University
Lead Sponsor
A
Aljazeera Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This randomized, double-blind, placebo-controlled, will evaluate whether oral hyoscine butylbromide or topical eutectic lidocaine-prilocaine (EMLA) spray reduces pain during hysterosalpingography (HSG) compared with placebo
CONDITIONS
Official Title
Oral Hyoscine vs. Topical EMLA vs. Placebo for Pain Reduction During Hysterosalpingography
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women undergoing hysterosalpingography (HSG) for infertility evaluation
- Regular menstrual cycles with the procedure scheduled in the proliferative phase (days 6-12)
- Negative urine pregnancy test on the day of the procedure
You will not qualify if you...
- Known allergy to hyoscine, lidocaine, or prilocaine
- Use of systemic painkillers, sedatives, or antispasmodics within 24 hours before HSG
- Chronic pelvic pain or severe menstrual cramps requiring regular pain medication
- Active pelvic infection, uterine abnormalities, or cervical narrowing requiring anesthesia
- History of allergy to contrast dye
- Inability to cooperate with pain reporting using the visual analog scale (VAS)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Al Gezeera Hospital
Giza, Egypt
Actively Recruiting
Research Team
M
Mahmoud alalfy, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here